Objective： To evaluate the clinical efficacy and quality of life of combined warming needle and patented Chinese medicine for patients with irritable bowel syndrome （IBS） due to liver-qi stagnation with spleen defi...Objective： To evaluate the clinical efficacy and quality of life of combined warming needle and patented Chinese medicine for patients with irritable bowel syndrome （IBS） due to liver-qi stagnation with spleen deficiency. Method： Sixty IBS cases were randomized into a treatment or control group by single-blind method. Warming needles on Tianshu （ST 25） and Dachangshu （BL 25） combined with patented Chinese medicine were adopted for cases in the treatment group, whereas the patented Chinese medicine alone was adopted in the control group. Results： The therapeutic efficacies in the two groups did not show substantial differences. The main symptoms were significantly improved after the treatment （P〈0.01）. After 2 weeks of treatment, the cases in the treatment group obtained a better improvement than the control group （P〈0.01, P〈0.05） in the severity or frequency of abdominal pain, abdominal distension, restlessness, insomnia, anxiety, suspiciousness, and loose stools with a sense of incomplete emptying. The patient＇s quality of life was improved in both groups （P〈0.01）. Conclusion： Both treatment methods could improve the clinical symptoms and increase the patient＇s quality of life. The total effective rate in the treatment group was slightly higher than the control group. Also, the combined warming needle and Chinese herbs could improve the main symptoms in a faster way.展开更多
目的:比较针刺天枢、大肠俞为主与口服西药马来酸曲美布汀治疗肠易激综合征的疗效差异。方法:将40例患者随机分针刺组和西药组,每组20例。针刺组针刺天枢、大肠俞为主,采用子午捣臼法,每天1次;西药组口服马来酸曲美布汀胶囊,每次2粒,每...目的:比较针刺天枢、大肠俞为主与口服西药马来酸曲美布汀治疗肠易激综合征的疗效差异。方法:将40例患者随机分针刺组和西药组,每组20例。针刺组针刺天枢、大肠俞为主,采用子午捣臼法,每天1次;西药组口服马来酸曲美布汀胶囊,每次2粒,每日3次,两组均治疗4周后评定疗效。结果:两组患者治疗后腹痛时间、腹痛频率、排便形状异常比率、排便通过异常比率、黏液便比率、排便时腹胀或腹痛积分均较治疗前降低(均P<0.01),且针刺组较西药组降低更显著(总积分:16.70±2.40 vs 15.70±3.01,P<0.01)。针刺组总有效率为95.0%(19/20),优于西药组的70.0%(14/20)(P<0.05)。结论:针刺天枢、大肠俞为主可明显改善肠易激综合征患者的临床症状,其疗效优于口服西药马来酸曲美布汀。展开更多
文摘Objective： To evaluate the clinical efficacy and quality of life of combined warming needle and patented Chinese medicine for patients with irritable bowel syndrome （IBS） due to liver-qi stagnation with spleen deficiency. Method： Sixty IBS cases were randomized into a treatment or control group by single-blind method. Warming needles on Tianshu （ST 25） and Dachangshu （BL 25） combined with patented Chinese medicine were adopted for cases in the treatment group, whereas the patented Chinese medicine alone was adopted in the control group. Results： The therapeutic efficacies in the two groups did not show substantial differences. The main symptoms were significantly improved after the treatment （P〈0.01）. After 2 weeks of treatment, the cases in the treatment group obtained a better improvement than the control group （P〈0.01, P〈0.05） in the severity or frequency of abdominal pain, abdominal distension, restlessness, insomnia, anxiety, suspiciousness, and loose stools with a sense of incomplete emptying. The patient＇s quality of life was improved in both groups （P〈0.01）. Conclusion： Both treatment methods could improve the clinical symptoms and increase the patient＇s quality of life. The total effective rate in the treatment group was slightly higher than the control group. Also, the combined warming needle and Chinese herbs could improve the main symptoms in a faster way.
文摘目的:比较针刺天枢、大肠俞为主与口服西药马来酸曲美布汀治疗肠易激综合征的疗效差异。方法:将40例患者随机分针刺组和西药组,每组20例。针刺组针刺天枢、大肠俞为主,采用子午捣臼法,每天1次;西药组口服马来酸曲美布汀胶囊,每次2粒,每日3次,两组均治疗4周后评定疗效。结果:两组患者治疗后腹痛时间、腹痛频率、排便形状异常比率、排便通过异常比率、黏液便比率、排便时腹胀或腹痛积分均较治疗前降低(均P<0.01),且针刺组较西药组降低更显著(总积分:16.70±2.40 vs 15.70±3.01,P<0.01)。针刺组总有效率为95.0%(19/20),优于西药组的70.0%(14/20)(P<0.05)。结论:针刺天枢、大肠俞为主可明显改善肠易激综合征患者的临床症状,其疗效优于口服西药马来酸曲美布汀。
